# A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation

> **NCT03434977** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-536

## Key facts

- **NCT ID:** NCT03434977
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2018-03-11
- **Final completion:** 2018-03-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03434977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03434977, "A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03434977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*